Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 11-12, 2007, Pages 947-955

  Tellado, Jose M ^a   Sen, Shuvayu S ^b   Caloto, M Teresa ^c   Kumar, Ritesh N ^b   Nocea, Gonzalo ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZOLINE; CARBAPENEM; CEFOXITIN; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROGNOSIS; REOPERATION; SPAIN; TREATMENT DURATION; TREATMENT OUTCOME;

ABDOMEN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MIDDLE AGED; SPAIN; TREATMENT OUTCOME;

EID: 36349026958     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701449377     Document Type: Article

References (21)

1. Christou, NV, Turgeon, P., Wassef, R., Rotstein, O., Bohnen, J. and Potvin, M. (1996) Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. Arch Surg., 131, pp. 1193-1201.
2. Solomkin, JS, Mazuski, JE, Baron, EJ, Sawyer, RG, Nathens, AB and DiPiro, JT (2003) Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clinical Infectious Diseases., 37, pp. 997-1005.
3. Mazuski, JE, Swyer, RG, Nathens, AB, DiPiro, JT, Schein, M. and Kudsk, KA (2002) The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-abdominal Infections: An Executive Summary. Surgical Infections., 3, pp. 161-173.
4. Bohnen, JM, Solomkin, JS, Dellinger, EP, Bjornson, HS and Page, CP. (1992) Guidelines for clinical care: Anti-infective agents for intra-abdominal infection. Surgical Infection Society policy statement. Arch Surg., 127, pp. 83-89.
5. Mosdell, DM, Morris, DM, Voltura, A., Pitcher, DE, Twiest, MW and Milne, RL (1991) Antibiotic treatment for surgical peritonitis. Ann Surg., 214, pp. 543-549.
6. Falagas, ME, Barefoot, L., Griffith, J., Ruthazar, R. and Snydman, DR. (1996) Risk factors leading to clinical failure in 10 treatments of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis., 15, pp. 913-921.
7. Quinn, JP. (1997) Rational antibiotic therapy for intra-abdominal infection. AM J Surg., 349, pp. 517-518.
8. Schein, M. (1992) Management of severe intra-abdominal infection. Surg Ann., 24, pp. 47-68.
9. Christou, NV, Barie, PS, Dellinger, EP, Waymack, JP and Stone, HH. (1993) Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. Arch Surg., 128, pp. 193-198.
10. Hopkins, JA, John, CH and Wilson, SE. (1993) Susceptibility of intra-abdominal isolates at operation: A predictor of postoperative infection. Am Surg., 59, pp. 791-796.
11. Bratzler, DW, Houck, PM, Richards, C., Steele, L., Dellinger, EP and Fry, DE (2005) Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg., 140, pp. 174-182.
12. Pons-Busom, M., Aguas-Compaired, M., Delas, J. and Eguileor-Partearroyo, B. (2004) Compliance with local guidelines for antibiotic prophylaxis in surgery. Infect Control Hosp Epidemiol., 25, pp. 308-312.
13. Gul, YA, Hong, LC and Prasannan, S. (2005) Appropriate antibiotic administration in elective surgical procedures: Still missing the message. Asian J Surg., 28, pp. 104-108.
14. Bochicchio, GV, Baquero, F., Hsueh, PR, Paterson, DL, Rossi, F. and Snyder, TA (2006) In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect (Larchmt)., 7, pp. 537-545.
15. Pacelli, F., Doglietto, GB, Alfieri, S., Piccioni, E., Sgadari, A. and Gui, D. (1996) Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg., 131, pp. 641-645.
16. Condon, RE, Krepel, CJ and Edmiston, CE. (1995) Antibiotic resistance among intra-abdominal pathogens. Infectious Disease in Clinical Practice, 4:3, p. S150.
17. Sitges-Serra, A., Lopez, MJ, Girvent, M., Almirall, S. and Sancho, JJ. (2002) Post-operative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg., 89, pp. 361-367.
18. Teppler, H., McCarroll, K., Gesser, RM and Woods, GL. (2002) Surgical infections with Enterococcus: Outcome in patients treated with ertapenem versus piperacillin-tazobactam. Surg Infect (Larchmt)., 3, pp. 337-349.
19. Margenthaler, JA, Longo, WE, Virgo, KS, Johnson, FE, Oprian, CA and Henderson, WG (2003) Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg., 238, pp. 59-66.
20. Sotto, A., De Boever, CM, Fabbro-Peray, P., Gouby, A., Sirot, D. and Jourdan, J. (2001) Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. J Clin Microbiol., 39, pp. 438-444.
21. Skapinyecz, J., Smid, I., Juhasz, A., Jeney, C., Rozgonyi, F. and Kovacs, P. (2003) Planning of empirical antibiotic therapy for women with pelvic inflammatory diseases: A geographical area-specific study. Eur J Obstet Gynecol Reprod Biol., 111, pp. 183-188.